Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Ocul Surf. 2020 Nov 6;19:313–321. doi: 10.1016/j.jtos.2020.11.001

Fig. 8.

Fig. 8.

(Left Panel) Inhibition of HSV-1 infection of human primary corneal epithelial cells by S-pep7B. Following 1 h absorption of HSV-1 onto human primary corneal epithelial cells, the cells were washed thoroughly to remove any unabsorbed virus and then treated with S-pep7B at different dilutions. At 72 h post-treatment, virus titers in the culture media were determined by plaque reduction assays using Vero cells. (Right Panel) S-pep7B cytotoxicity in the primary cells was determined after 24 h by measuring ATP content. All data represents mean±SD obtained from two independent experiments in duplicate.